Nonlinear random effects mixture models: Maximum likelihood estimation via the EM algorithm

Computational Statistics and Data Analysis

Volumn 51, Issue 12, 2007, Pages 6614-6623

  Wang, Xiaoning ^a   Schumitzky, Alan ^b   D'Argenio, David Z ^a  

^a University of Southern California ^*  (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Finite mixture models; Mixed effects models; Pharmacokinetics pharmacodynamics

Indexed keywords

ALGORITHMS; LINEARIZATION; MATHEMATICAL MODELS; MAXIMUM LIKELIHOOD ESTIMATION; NONLINEAR ANALYSIS; PHARMACOKINETICS; POLYMORPHISM;

FINITE MIXTURE MODELS; MIXED EFFECTS MODELS; NONLINEAR RANDOM EFFECTS MODELS;

RANDOM PROCESSES;

EID: 34547188255     PISSN: 01679473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csda.2007.03.008     Document Type: Article

References (18)

1. Beal S.L., and Sheiner L.B. NONMEM User's Guide, Part I (1979), San Francisco: Division of Clinical Pharmaology, University of California
2. Davidian M., and Gallant A.R. The non-linear mixed effects model with a smooth random effects density. Biometrika 80 (1993) 475-488
3. Davidian M., and Giltinan M. Nonlinear Models for Repeated Measurement Data (1995), Chapman and Hall, New York
4. Dempster A.P., Laird N., and Rubin D.B. Maximum likelihood from incomplete data via the EM algorithm. J. Roy. Statist. Soc. B 39 (1977) 1-38
5. Evans W.E., and Relling M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286 (1999) 487-491
6. Geweke J. Bayesian inference in econometric models using Monte Carlo integration. Econometrica 57 (1989) 1317-1340
7. Kuhn E., and Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. Comput. Statist. Data Anal. 49 (2005) 1020-1038
8. Mallet A. A maximum likelihood estimation method for random coefficient regression models. Biometrika 73 (1986) 645-656
9. McLachlan G.J., and Peel D. Finite Mixture Models (2000), Wiley, New York
10. Ng C.M., Joshi A., Dedrick R.L., Garovoy M.R., and Bauer R.J. Pharmacokinetic-pharmacodynamic-efficacy analysis of Efalizumab in patients with moderate to severe psoriasis. Pharm. Res. 77 (2005) 1088-1100
11. Philppou A., and Roussas G. Asymptotic normality of the maximum likelihood estimate in the independent but not identically distributed case. Ann. Inst. Statist. Math. 27 (1975) 45-55
12. Rosner G.L., and Muller P. Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models. J. Pharmacokinet. Biopharm. 25 (1997) 209-234
13. Schumitzky, A., 1995. EM Algorithms and two stage methods in pharmacokinetic population analysis. In: D.Z. D'Argenio (Ed.), Advanced methods of Pharmacokinetic and Pharmacodynamic Systems Analysis, vol. II, Plenum Press, New York, pp. 145-160.
14. Sheiner L.B., Rosenberg B., and Melmon K.L. Modeling of individual pharmacokinetics for computer-aided drug dosing. Comput. Biomed. Res. 5 (1972) 441-459
15. Tseng P. An analysis of the EM algorithm and entropy-like proximal point methods. Math. Oper. Res. 29 (2005) 27-44
16. Wakefiled J.C., and Walker S.G. Bayesian nonparametric population models: formulation and comparison with likelihood approaches. J. Pharmacokinet. Biopharm. 25 (1997) 235-253
17. Walker S. An EM algorithm for nonlinear random effects models. Biometrics. 52 (1996) 934-944
18. Wu C.F. On the convergence properties of the EM algorithm. Ann. Statist. 11 (1983) 95-103